# Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital Center

> **NCT04493827** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 114 (actual)

## Conditions studied

- Adenocarcinoma of Lung Stage IV
- Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in, Somatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04493827
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493827, "Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital Center". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04493827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*